已收盘 04-02 16:00:00 美东时间
-0.006
-0.02%
Infracap Small Cap Income ETF (SCAP) declares $0.245/share monthly dividend, 2.1% increase from prior dividend of $0.240. Forward yield 8.48% Payable March 31; for shareholders of record March 30; ex-...
03-27 20:05
Rocket Lab Corp (NASDAQ: RKLB) shares fell in premarket trading due to a delay in its first Neutron rocket launch to late 2026.
02-27 20:36
Rocket Lab Corp (NASDAQ:RKLB) reports financial results for the fourth quarter after the market close on Thursday.
02-27 05:32
UPDATE 1-Pandora settles comedians' lawsuit over streaming royalties Adds comment from SiriusXM in paragraph 2 By Blake Brittain Feb 2 (Reuters) - SiriusXM's [RIC:RIC:SXRI.UL] Pandora Media has settled a lawsuit from prominent comedians including the estates of Robin Williams and George Carlin that
02-03 06:31
Pandora settles comedians' lawsuit over streaming royalties By Blake Brittain Feb 2 (Reuters) - Sirius XM's [RIC:RIC:SXRI.UL] Pandora Media has settled a lawsuit from prominent comedians including the estates of Robin Williams and George Carlin that accused the company of failing to pay to stream th
02-03 06:22
Dec 23 (Reuters) - Jamf Holding Corp JAMF.O: JAMF NAMED A LEADER IN THREE IDC MARKETSCAPE REPORTS FOR UNIFIED ENDPOINT MANAGEMENT Source text: ID:nBw5bNJT5a Further company coverage: JAMF.O ((Reuters....
2025-12-23 22:41
Dec 17 (Reuters) - MOENGAGE SECURES ADDITIONAL $180 MILLION IN SERIES F FUNDING; COMPLETES LIQUIDITY EVENT FOR EMPLOYEES & INVESTORS MOENGAGE: LATEST INVESTMENT WAS LED BY NEW INVESTORS CHRYSCAPITAL A...
2025-12-17 22:21
Dec 10 (Reuters) - Quantumscape Corp QS.N: QUANTUMSCAPE TO TRANSFER STOCK EXCHANGE LISTING TO NASDAQ QUANTUMSCAPE - TRANSFER EFFECTIVE DECEMBER 22, 2025; TRADING BEGINS DECEMBER 23 QUANTUMSCAPE - TICK...
2025-12-10 19:55
Dec 4 (Reuters) - High Roller Technologies Inc ROLR.A: HIGH ROLLER STRENGTHENS LEADERSHIP TEAM, APPOINTING CARLO SCAPPATICCI AS CHIEF MARKETING OFFICER AND FRANCES CONG AS DIRECTOR OF MARKETING Source...
2025-12-04 22:06
Nov 13 (Reuters) - ImmunoScape: IMMUNOSCAPE: ENTERED IN-LICENSING DEAL WITH CUE BIOPHARMA FOR DEVELOPMENT OF NEW CLASS OF THERAPIES TO ATTACK SOLID TUMOR CANCERS Source text: ID:nBw8LPGPFa Further com...
2025-11-14 02:37